Advanced Search

Oncology & Hematology Coding Alert

Anti-emesis:

4 Tips Help You Regain Confidence To Submit Claim For Oral Chlorpromazine Hydrochloride

Published on Fri Apr 17, 2015

Keep in mind the 48-hour period timeline. You may miss out on payment if you ignore essentials for oral anti-emesis, like the allowable period of covered therapy, documentation for chemotherapy, and substitution of intravenous options. You report code Q0161 (Chlorpromazine hydrochloride, 5 mg, oral, FDA approved prescription anti-emetic, for use as a complete therapeutic substitute for an IV anti-emetic at [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All